앱클론

174900KOSDAQ

50.3 / 100

Reference Date: 2026-09-08

Financial Score15.0 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure12.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 22.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Appclone is a biotech company specializing in the development of monoclonal antibody-based pharmaceuticals. It focuses on creating 'Biosynergy' drugs that enhance efficacy when combined with existing medications and 'Biounique' antibodies with distinct mechanisms of action for monotherapy. The company also leverages its 'Affibody' technology and human antibody library to develop innovative treatment solutions.

Number of Employees

66people

Average Salary

57.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

7.21Industry Average 1.200.0Point

6.0x industry avg (risky)

ROE

-39.86Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

1.58Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲41.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼23.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -45.9% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
앱클론, 차세대 이중항체 ‘AM105’ 일본 특허 확보…글로벌 권리 확...
앱클론이 일본에서 차세대 이중항체 'AM105'의 핵심 기술에 대한 특허를 확보함으로써 글로벌 시장 진출에 유리한 위치를 확보했다.
Positive
앱클론, 이중항체 ‘AM105’ 국내 특허 등록…글로벌 기술이전 추진
앱클론의 이중항체 신약 'AM105' 핵심 기술 국내 특허 등록으로 글로벌 시장 진출 기대감 상승.
Positive
코스닥 6% 급등에 매수 사이드카 발동…850선 눈앞
코스닥 급등으로 앱클론 포함 종목들의 매수 사이드카 발동, 긍정적 시장 분위기 반영.

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 21,850Won52-week high 89,10052-week low 11,990

1-month return0.0Point

1m -21.96% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 1Neutral 1Negative 0

Positive[기재정정]단일판매ㆍ공급계약체결(자율공시)2026-08-31
Neutral반기보고서 (2026.06)2026-08-13